Long-term Dynamics of Measles Virus–Specific Neutralizing Antibodies in Children Vaccinated Before 12 Months of Age
Clinical Infectious Diseases·
- DOI
- 10.1093/cid/ciae537
- PMID
- 39492687
- PMCID
- PMC12043057
- OpenAlex
- W4404049162
- Study type
- Journal article
- Publisher
- Oxford University Press (OUP)
- Article type
- journal-article
- Integrity
- current
Why this research matters now
Routine infant immunization below the eight-and-a-half-month threshold may undermine sustained community-level protection, reinforcing recommendations to reserve early dosing for emergency outbreak response or elevated exposure environments.
Structured evidence summary
Research question
How does administering the initial measles, mumps, and rubella vaccine before twelve months of age influence the durability of measles-specific neutralizing antibodies compared to standard scheduling?
Study design
A longitudinal observational comparison tracking humoral immune markers across a six-year interval between an early-dosing cohort and a standard-scheduling control group.
Population and setting
Pediatric participants enrolled in Myanmar who received supplemental early immunization between six and twelve months alongside routine booster schedules, contrasted with peers following conventional timing.
Main findings
Initial immunization timing significantly associates with long-term antibody persistence. Infants primed prior to eight and a half months demonstrate accelerated humoral decline and frequently fall below protective thresholds within six years, despite achieving initial seroconversion.
Public-health relevance
Routine infant immunization below the eight-and-a-half-month threshold may undermine sustained community-level protection, reinforcing recommendations to reserve early dosing for emergency outbreak response or elevated exposure environments.
Important limitations
The summary relies exclusively on the supplied single-article abstract and metadata, lacking full methodological transparency. Original manuscript review is required for decision-grade interpretation.
GIDS interpretation
The record situates pediatric immunogenicity kinetics within broader measles monitoring frameworks. It clarifies how primary dose timing shapes durable humoral coverage, offering reference points for tracking waning protection in vaccinated populations without implying active outbreak detection.
Related GIDS surveillance
Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.
Evidence relationships
This article has 14 auditable classifier relationships to diseases, places, topics, and study design.